Applications for The Pershing Square Sohn Cancer Research Alliance (PSSCRA) Prize for Young Investigators in Cancer Research are officially open. The prize of $200,000 per year for up to 3 years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue explorative and high-risk/high-reward research at a stage when traditional funding is lacking.
Now entering its fourth year, the highly competitive Prize aims to help bridge the gap between academia and the business community while supporting young scientists at a formative stage in their careers. In order to facilitate these collaborations, each Prize winner is given a mentor in the pharmaceutical industry and the opportunity to present his or her work to scientific and business audiences.
In order to apply for the Prize, applicants must have between 2 to 8 years of experience running their own laboratories and must have a PhD, MD, or MD-PhD (or equivalent). The deadline to submit the Letter of Intent is November 7, 2016. More details on the application process, including the full eligibility criteria, and on the Pershing Square Sohn Cancer Research Alliance are available online.
In May 2016, PSSCRA awarded the Prize to seven recipients: Omar Abdel-Wahab, MD, of Memorial Sloan Kettering Cancer Center; Uttiya Basu, PhD, of Columbia University Medical Center; Christopher Mason, PhD, of Weill Cornell Medicine; Agnel Sfeir, PhD, of NYU School of Medicine; Samuel Sidi, PhD, of Icahn School of Medicine at Mount Sinai; Christopher Vakoc, MD, PhD, of Cold Spring Harbor Laboratory; and Andrea Ventura, MD, PhD, of Memorial Sloan Kettering Cancer Center.